
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Opthea Limited is a biotechnology business based in Australia. Opthea shares (OPT) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Opthea has a trailing 12-month revenue of around $149,575..
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $1.165 - $3.65 |
---|---|
50-day moving average | $2.0117 |
200-day moving average | $2.3941 |
Target price | $1.29 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.09 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$2 on 2021-01-25
1 week (2021-01-18) | -0.50% |
---|---|
1 month (2020-12-24) | 3.09% |
3 months (2020-10-23) | -14.53% |
6 months (2020-07-24) | -26.47% |
1 year (2020-01-24) | -44.60% |
---|---|
2 years (2019-01-25) | 156.41% |
3 years (2018-01-24) | 214.96% |
5 years (2016-01-25) | 387.80% |
Revenue TTM | $149,575 |
---|---|
Gross profit TTM | $-393,700 |
Return on assets TTM | -28.96% |
Return on equity TTM | -34.46% |
Profit margin | 0% |
Book value | 0.241 |
Market capitalisation | $672 million |
TTM: trailing 12 months
We're not expecting Opthea to pay a dividend over the next 12 months.
Opthea 's shares were split on 15 August 1997.
Over the last 12 months, Opthea 's shares have ranged in value from as little as $1.165 up to $3.65. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Opthea 's is 0.1553. This would suggest that Opthea 's shares are less volatile than average (for this exchange).
Opthea Limited, a biotechnology company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3 for the treatment of wet age-related macular degeneration and diabetic macular edema. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.
From the best lip exfoliator to the top product for the body, we rounded up the seven best exfoliators you can get in Australia right now.
From the best overall face moisturiser for dry skin to the best body moisturiser, hand moisturiser and tinted moisturiser for dry skin, these are the best 7 moisturisers for dry skin you can buy in Australia right now.
From the best RC plane for beginners to the top model for aerial photography, these are the six best RC planes in Australia right now.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.